THE MUTANT ASN(291)-]SER HUMAN LIPOPROTEIN-LIPASE IS ASSOCIATED WITH REDUCED CATALYTIC ACTIVITY AND DOES NOT INFLUENCE BINDING TO HEPARIN

被引:27
|
作者
BUSCA, R
PEINADO, J
VILELLA, E
AUWERX, J
DEEB, SS
VILARO, S
REINA, M
机构
[1] UNIV BARCELONA,DEPT CELL BIOL,E-08028 BARCELONA,SPAIN
[2] UNIV BARCELONA,DEPT BIOCHEM & MOLEC BIOL,E-08028 BARCELONA,SPAIN
[3] HOSP ST JOAN,BIOMED RES CTR,E-43201 REUS,SPAIN
[4] INST PASTEUR,DEPT ATHEROSCLEROSE,BIOL REGULAT EUCARYOTES LAB,F-59019 LILLE,FRANCE
[5] UNIV WASHINGTON,DEPT GENET,SEATTLE,WA 98195
[6] UNIV WASHINGTON,DEPT MED,SEATTLE,WA 98195
关键词
HYPERTRIGLYCERIDEMIA; LIPOPROTEIN LIPASE; MUTATION;
D O I
10.1016/0014-5793(95)00582-T
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Lipoprotein lipase (LPL) plays a central role in triglyceride metabolism, regulating the catabolism of triglyceride-rich lipoprotein particles, LPL performs its hydrolytic action attached to heparan sulfate proteoglycans at the luminal surface of capillary endothelial cells, We have assessed the effect of the Asn(291) --> Ser (N291S) substitution found in LPL gene from a human hyperlipemic patient, Our results showed that both the wild-type (WT) and N291S hLPL expressed in COS1 cells were secreted to the extracellular medium, and presented similar intracellular distibution patterns, Furthermore, heparin-Sepharose affinity chromatography assays revealed normal heparin affinity of the N291S hLPL, In addition, both the mutant and the WT protein bound to the surface of human fibroblasts and untransfected COS1 cells, Interestingly, disminished LPL specific activity was observed in the extracellular medium from mutant expressing cells, Therefore the lack of normal LPL activity in patients harbouring such a mutation could be the cause of their hyperlipemic disorder.
引用
收藏
页码:257 / 262
页数:6
相关论文
共 22 条
  • [1] A LIPOPROTEIN-LIPASE MUTATION (ASN291SER) IS ASSOCIATED WITH REDUCED HDL CHOLESTEROL LEVELS IN PREMATURE ATHEROSCLEROSIS
    REYMER, PWA
    GAGNE, E
    GROENEMEYER, BE
    ZHANG, HF
    FORSYTH, I
    JANSEN, H
    SEIDELL, JC
    KROMHOUT, D
    LIE, KE
    KASTELEIN, J
    HAYDEN, MR
    NATURE GENETICS, 1995, 10 (01) : 28 - 34
  • [2] A FREQUENTLY OCCURRING MUTATION IN THE LIPOPROTEIN-LIPASE GENE (ASN291SER) CONTRIBUTES TO THE EXPRESSION OF FAMILIAL COMBINED HYPERLIPIDEMIA
    REYMER, PWA
    GROENEMEYER, BE
    GAGNE, E
    MIAO, L
    APPELMAN, EEG
    SEIDEL, JC
    KROMHOUT, D
    BIJVOET, SM
    VANDEOEVER, K
    BRUIN, T
    HAYDEN, MR
    KASTELEIN, JJP
    HUMAN MOLECULAR GENETICS, 1995, 4 (09) : 1543 - 1549
  • [3] POSTPRANDIAL RETINYL PALMITATE RESPONSE SUPPORTS EVIDENCE FOR A FUNCTIONAL EFFECT OF THE ASN291SER MUTATION IN THE LIPOPROTEIN-LIPASE GENE
    PIMSTONE, SN
    GAGNE, E
    CLEE, SM
    STEIN, EA
    HAYDEN, MR
    CIRCULATION, 1995, 92 (08) : 2350 - 2350
  • [4] A common substitution (Asn291Ser) in lipoprotein lipase is associated with increased risk of ischemic heart disease
    Wittrup, HH
    TybjaergHansen, A
    Abildgaard, S
    Steffensen, R
    Schnohr, P
    Nordestgaard, BG
    JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (07): : 1606 - 1613
  • [5] The lipoprotein lipase (Asn291->Ser) mutation is associated with elevated lipid levels in families with familial combined hyperlipidaemia
    Hoffer, MJV
    Bredie, SJH
    Boomsma, DI
    Reymer, PWA
    Kastelein, JJP
    deKnijff, P
    Demacker, PNM
    Stalenhoef, AFH
    Havekes, LM
    Frants, RR
    ATHEROSCLEROSIS, 1996, 119 (02) : 159 - 167
  • [6] A heparin-binding deficient mutant of endothelial lipase has markedly reduced catalytic and lipoprotein bridging activities
    Badellino, KO
    Marchadier, DH
    Kitajima, K
    Fuki, IV
    Blanchard, N
    Glick, JM
    Rader, DJ
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2002, 22 (05) : A38 - A38
  • [7] WATER ACTIVITY DOES NOT INFLUENCE THE ENANTIOSELECTIVITY OF LIPASE PS AND LIPOPROTEIN-LIPASE IN ORGANIC-SOLVENTS
    BOVARA, R
    CARREA, G
    OTTOLINA, G
    RIVA, S
    BIOTECHNOLOGY LETTERS, 1993, 15 (02) : 169 - 174
  • [8] A monoclonal antibody against human lipoprotein lipase inhibiting heparin binding without affecting catalytic activity
    Cadelis, F
    Julien, P
    Valet, JP
    Deshaies, Y
    Murthy, MRV
    Lupien, PJ
    BIOCHEMISTRY AND CELL BIOLOGY, 1996, 74 (03) : 383 - 389
  • [9] HUMAN LIPOPROTEIN-LIPASE - RELATIONSHIP OF ACTIVITY, HEPARIN AFFINITY, AND CONFORMATION AS STUDIED WITH MONOCLONAL-ANTIBODIES
    PETERSON, J
    FUJIMOTO, WY
    BRUNZELL, JD
    JOURNAL OF LIPID RESEARCH, 1992, 33 (08) : 1165 - 1170
  • [10] Direct effects of the Asn291Ser variant of the human lipoprotein lipase on the catabolism of VLDL1 and VLDL2 in vivo
    Pietzsch, J
    Julius, U
    Nitzsche, S
    Gehrisch, S
    Leonhardt, W
    Jaross, W
    Hanefeld, M
    ATHEROSCLEROSIS, 1997, 134 (1-2) : 26 - 27